|Day's Range||161.12 - 162.90|
|52 Week Range||114.53 - 199.43|
|PE Ratio (TTM)||7.09|
|Earnings Date||Jul 25, 2017 - Jul 31, 2017|
|Dividend & Yield||1.12 (0.69%)|
|1y Target Est||161.93|
Follow Up: Yahoo! | Review | Preview Shares of drug distributor McKesson have had a wild ride since we wrote positively about the company nearly a year ago (“McKesson Shares Could Rise 15% or More,” June 11, 2016). The stock (MCK) was recently at $162 and change, 12% below where it traded when that story appeared, but well above the $124 it plunged to last fall, after it cut the earnings guidance for its fiscal year ended this March. The stock slid 23% on Oct. 28 alone, on fear that price hikes for branded drugs were slowing.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to McKesson Corp. Here are 5 ETFs with the largest exposure to MCK-US. Comparing the performance and risk of McKesson Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
McKesson Corporation today announced that James Beer, executive vice president and chief financial officer, will present at the Goldman Sachs 38th Annual Global Healthcare Conference in Rancho Palos Verdes at 9:20 a.m.